特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

放射線治療装置の世界市場:考察・機会分析・市場シェア・予測

Global Radiotherapy Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

発行 Occams Business Research & Consulting Pvt. Ltd. 商品コード 572874
出版日 ページ情報 英文 190 Pages
納期: お問合せ
価格
本日の銀行送金レート: 1USD=107.17円で換算しております。
放射線治療装置の世界市場:考察・機会分析・市場シェア・予測 Global Radiotherapy Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023
出版日: 2017年08月31日 ページ情報: 英文 190 Pages
概要

当レポートでは、放射線治療装置の世界市場について調査し、市場の概要、製品・タイプ・用途・エンドユーザー・地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会・課題の分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 イントロダクション

  • エグゼクティブサマリー
  • 推計手法

第2章 市場概要

  • 放射線治療装置の世界市場:発展と変遷
  • 市場の定義と範囲
  • 産業構造
  • 市場分析
  • 予測分析
  • 戦略分析
    • 投資 vs 導入モデル
    • 全方位的産業分析
    • ファイブフォース分析
    • シーソー分析
    • 投資収益率(ROI)分析
    • ギャップ分析
    • 特許分析
    • 価格分析
    • パイプライン分析
    • コンシューマー分析・主な購買基準
  • 競合分析
    • 主要戦略とその分析
    • 市場シェアおよび上位企業の分析
  • 戦略提言・総論
    • 地域別の投資機会
    • 新用途の市場機会
    • 最速成長市場の投資機会

第3章 市場の決定要因

  • 促進要因
  • 阻害要因
  • 市場機会
  • 課題

第4章 放射線治療装置の世界市場:セグメント別

  • 製品別
    • 外部照射装置
    • 内部照射装置・小線源治療装置
    • 全身照射装置
  • タイプ別
    • 外部照射治療
    • 内部照射治療
    • 全身照射治療
  • 用途別
    • 外部照射治療
    • 内部照射治療
  • エンドユーザー別
    • 病院
    • 癌研究機関
    • 外来センター・放射線治療センター

第5章 競合情勢

  • 主な戦略
    • 買収・合併
    • 合弁事業
    • 新製品の投入
    • パートナーシップ
  • 上位10社の分析

第6章 地域市場の分析

  • 意思支援データベース・推計手法
  • 市場セグメントの比較分析
  • 市場機会のマトリクス
  • 放射線治療装置の世界市場:地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第7章 企業プロファイル

  • ACCURAY INCORPORATED
  • COVIDEN PLC OVERVIEW
  • C.R. BARD , INC
  • ELEKTA AB
  • IBA
  • MEVION MEDICAL SYSTEMS, INC
  • 三菱電機
  • NORDIAN, INC
  • PANACEA MEDICAL TECHNOLOGIES PVT. LTD
  • P-CURE LTD
  • PRONOVA SOLUTIONS , LLC
  • RAYSEARCH LABORATORIES
  • THERAGENICS CORPORATION
  • VARIAN MEDICAL SYSTEMS , INC
  • VIEWRAY INC.

図表リスト

目次
Product Code: HME-7470917

The global radiotherapy device market is impeded to grow at a significant CAGR of 6.8% during the forecast period of 2016-2023. Radiotherapy use high-energy rays to treat disease, this therapy can be given both internally and externally. Basically radiotherapy works for destroying cancer cells in the area that's been affected; at the time of treatment usually normal cells can also be damaged by radiotherapy. Normal cells can recover after radiotherapy then cancer cells, as these cancer cells cannot repair themselves after radiotherapy. Key drivers for the global radiotherapy device market are rising incidence and prevalence of cancer, rising technological advancements such as stereotactic body radiation therapy, advancements in proton therapy, rising adoption of radiotherapy devices and procedures, growing geriatric population as persons over 65 years reported for 60% of newly diagnosed malignancies and 70% of all cancer deaths and increasing number of conferences and symposia focusing on spreading awareness about the benefits of radiotherapy. However, the major restraining factors of the global radiotherapy device market are lack of adequate healthcare infrastructure and lack of trained personnel. Apart from this, the major challenges present in the market are difficulties in visualizing tumors during radiation procedures and affordability and accessibility of treatment. However, to overcome these market challenges, key opportunities for the global radiotherapy device market are emerging markets and rising investments to meet the increased demand for cancer treatment.

Global radiotherapy device market covers segmentation analysis of product, type, applications and end-users. The market further segmented by its product which is External beam radiotherapy, internal beam radiotherapy/brachytherapy and systemic radiotherapy. On the basis of type, the market is classified into external beam radiotherapy, internal beam radiotherapy and systemic radiotherapy. On the basis of application, the market is classified into external beam radiation therapy and internal beam radiotherapy/brachytherapy. Further, on the basis of end-user the global radiotherapy device market is classified into hospitals, cancer research institutes and ambulatory & radiotherapy centers. North America dominates the global radiotherapy device market in terms of revenue due to growing number of cancer cases, rising technological advancements in radiotherapy equipment, also increasing focus of key vendors on expanding their presence in North America. Moreover, Asia-Pacific is anticipated to be the fastest growing region due to improvements in healthcare infrastructure, increasing aging population and rising number of cancer cases in this region.

Key market vendors for the global radiotherapy device market include Varian Medical Systems, Inc. (U.S) Mitsubishi Electric Corporation (Japan), RaySearch Laboratories (Sweden), Mevion Medical Systems. Inc (U.S), Ion Beam Applications (IBA) (Belgium). These companies are using various strategies such as merger & acquisitions, collaboration, partnership and product launch to hold large market share.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. GLOBAL RADIOTHERAPY DEVICE MARKET: EVOLUTION & TRANSITION
  • 2.2. MARKET DEFINITION & SCOPE
  • 2.3. INDUSTRY STRUCTURE
  • 2.4. TOTAL MARKET ANALYSIS
    • 2.4.1. TOP 5 FINDINGS
    • 2.4.2. TOP 5 OPPORTUNITY MARKETS
    • 2.4.3. TOP 5 COMPANIES
    • 2.4.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.5. ESTIMATION ANALYSIS
  • 2.6. STRATEGIC ANALYSIS
    • 2.6.1. INVESTMENT VS. ADOPTION MODEL
    • 2.6.2. 360 DEGREE INDUSTRY ANALYSIS
    • 2.6.3. PORTERS 5 FORCE MODEL
    • 2.6.4. SEE-SAW ANALYSIS
    • 2.6.5. ROI ANALYSIS
    • 2.6.6. GAP ANALYSIS
    • 2.6.7. PATENT ANALYSIS
    • 2.6.8. PRICING ANALYSIS
    • 2.6.9. PIPELINE ANALYSIS
    • 2.6.10. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
  • 2.7. COMPETITIVE ANALYSIS
    • 2.7.1. KEY STRATEGIES & ANALYSIS
    • 2.7.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
  • 2.8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.8.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.8.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.8.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. RISNG TECHNOLOGICAL ADVANCEMENTS
    • 3.1.2. RISING INCIDENCE AND PREVALENCE OF CANCER
    • 3.1.3. RISING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES
    • 3.1.4. GROWING GERIATRIC POPULATION
    • 3.1.5. INCREASING NUMBER OF CONFERENCES AND SYMPOSIA FOCUSING ON SPREADING AWARENESS ABOUT THE BENEFITS OF RADIOTHERAPY
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. LACK OF TRAINED PERSONNEL
    • 3.2.2. LACK OF ADEQUATE HEALTHCARE INFRASTRUCTURE
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. RISING INVESTMENTS TO MEET THE INCREASIND DEMAND FOR CANCER TREATMENT
    • 3.3.2. EMERGING MARKETS
  • 3.4. MARKET CHALLENGES
    • 3.4.1. AFFORDABILITY AND ACCESSIBILITY OF TREATMENT
    • 3.4.2. DIFFICULTIES IN VISUALIING TUMORS DURING RADIATION PROCEDURES

4. MARKET SEGMENTATION

  • 4.1. GLOBAL RADIOTHERAPY DEVICE MARKET BY PRODUCT
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION
      • 4.1.5.1. GLOBAL EXTERNAL BEAM RADIOTHERAPY MARKET
        • 4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.1.4. KEY CONCLUSIONS
      • 4.1.5.2. GLOBAL INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET
        • 4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.2.4. KEY CONCLUSIONS
      • 4.1.5.3. GLOBAL SYSTEMIC RADIOTHERAPY MARKET
        • 4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.3.4. KEY CONCLUSIONS
  • 4.2. GLOBAL RADIOTHERAPY DEVICE MARKET BY TYPE
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION
      • 4.2.5.1. GLOBAL EXETERNAL BEAM RADIOTHERAPY MARKET
        • 4.2.5.1.1. APPLICATION
        • 4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.1.4. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.1.5. KEY CONCLUSIONS
      • 4.2.5.2. GLOBAL INTERNAL BEAM RADIOTHERAPY MARKET
        • 4.2.5.2.1. APPLICATION
        • 4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.2.4. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.2.5. KEY CONCLUSIONS
      • 4.2.5.3. GLOBAL SYSTEMIC RADIOTHERAPY MARKET
        • 4.2.5.3.1. APPLICATION
        • 4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.3.4. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.3.5. KEY CONCLUSIONS
  • 4.3. GLOBAL RADIOTHERAPY DEVICE MARKET BY APPLICATION
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION
      • 4.3.5.1. GLOBAL EXTERNAL BEAM RADIATION THERAPY MARKET
        • 4.3.5.1.1. APPLICATION
        • 4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.1.4. KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.1.5. KEY CONCLUSIONS
      • 4.3.5.2. GLOBAL INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET
        • 4.3.5.2.1. APPLICATION
        • 4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.2.4. KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.2.5. KEY CONCLUSIONS
  • 4.4. GLOBAL RADIOTHERAPY DEVICE MARKET BY END-USER
    • 4.4.1. MARKET DEFINITION AND SCOPE
    • 4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.4.4. OPPORTUNITY MATRIX
    • 4.4.5. MARKET SEGMENTATION
      • 4.4.5.1. GLOBAL HOSPITALS MARKET
        • 4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.1.4. KEY CONCLUSIONS
      • 4.4.5.2. GLOBAL CANCER RESEARCH INSTITUTES MARKET
        • 4.4.5.2.1. APPLICATION
        • 4.4.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.2.4. KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.2.5. KEY CONCLUSIONS
      • 4.4.5.3. GLOBAL AMBULATORY & RADIOTHERAPY CENTERS MARKET
        • 4.4.5.3.1. APPLICATION
        • 4.4.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.3.4. KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.3.5. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF MERGER & ACQUISITION
    • 5.1.2. LIST OF JOINT VENTURE
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIP
  • 5.2. TOP 10 COMPANY ANALYSIS

6. GEOGRAPHICAL ANALYSIS

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GLOBAL RADIOTHERAPY DEVICE MARKET BY REGION 2014-2023 ($ MILLION)
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. RUSSIA
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
        • 6.4.2.2.5. REST OF EUROPE
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. AUSTRALIA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
        • 6.4.3.2.5. REST OF ASIA PACIFIC
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. ACCURAY INCORPORATED
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. STRATEGIC INITIATIVES
    • 7.1.4. SCOT ANALYSIS
    • 7.1.5. STRATEGIC ANALYSIS
  • 7.2. COVIDEN PLC OVERVIEW
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. STRATEGIC INITIATIVES
    • 7.2.4. SCOT ANALYSIS
    • 7.2.5. STRATEGIC ANALYSIS
  • 7.3. C.R. BARD , INC
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. STRATEGIC INITIATIVES
    • 7.3.4. SCOT ANALYSIS
    • 7.3.5. STRATEGIC ANALYSIS
  • 7.4. ELEKTA AB
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. STRATEGIC INITIATIVES
    • 7.4.4. SCOT ANALYSIS
    • 7.4.5. STRATEGIC ANALYSIS
  • 7.5. IBA (ION BEAM APPLICATIONS SA)
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. STRATEGIC INITIATIVES
    • 7.5.4. SCOT ANALYSIS
    • 7.5.5. STRATEGIC ANALYSIS
  • 7.6. MEVION MEDICAL SYSTEMS, INC
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. STRATEGIC INITIATIVES
    • 7.6.4. SCOT ANALYSIS
    • 7.6.5. STRATEGIC ANALYSIS
  • 7.7. MITSUBISHI ELECTRIC CORPORATION
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. STRATEGIC INITIATIVES
    • 7.7.4. SCOT ANALYSIS
    • 7.7.5. STRATEGIC ANALYSIS
  • 7.8. NORDIAN, INC
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. STRATEGIC INITIATIVES
    • 7.8.4. SCOT ANALYSIS
    • 7.8.5. STRATEGIC ANALYSIS
  • 7.9. PANACEA MEDICAL TECHNOLOGIES PVT. LTD
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. STRATEGIC INITIATIVES
    • 7.9.4. SCOT ANALYSIS
    • 7.9.5. STRATEGIC ANALYSIS
  • 7.10. P-CURE LTD
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. STRATEGIC INITIATIVES
    • 7.10.4. SCOT ANALYSIS
    • 7.10.5. STRATEGIC ANALYSIS
  • 7.11. PRONOVA SOLUTIONS , LLC
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. STRATEGIC INITIATIVES
    • 7.11.4. SCOT ANALYSIS
    • 7.11.5. STRATEGIC ANALYSIS
  • 7.12. RAYSEARCH LABORATORIES
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. STRATEGIC INITIATIVES
    • 7.12.4. SCOT ANALYSIS
    • 7.12.5. STRATEGIC ANALYSIS
  • 7.13. THERAGENICS CORPORATION
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. STRATEGIC INITIATIVES
    • 7.13.4. SCOT ANALYSIS
    • 7.13.5. STRATEGIC ANALYSIS
  • 7.14. VARIAN MEDICAL SYSTEMS , INC
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. STRATEGIC INITIATIVES
    • 7.14.4. SCOT ANALYSIS
    • 7.14.5. STRATEGIC ANALYSIS
  • 7.15. VIEWRAY INC.
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. STRATEGIC INITIATIVES
    • 7.15.4. SCOT ANALYSIS
    • 7.15.5. STRATEGIC ANALYSIS

LIST OF TABLES

  • 1. GLOBAL RADIOTHERAPY DEVICE MARKET BY PRODUCT 2014-2023 ($ MILLION)
  • 2. GLOBAL EXTERNAL BEAM RADIOTHERAPY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 3. GLOBAL INTERNAL BEAM RADIOTHERAPY/ BRACHYTHERAPY BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 4. GLOBAL SYSTEMIC RADIOTHERAPY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 5. GLOBAL RADIOTHERAPY DEVICE MARKET BY TYPE 2014-2023 ($ MILLION)
  • 6. GLOBAL EXTERNAL BEAM RADIOTHERAPY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 7. GLOBAL INTERNAL BEAM RADIOTHERAPY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 8. GLOBAL SYSTEMIC RADIOTHERAPY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 9. GLOBAL RADIOTHERAPY DEVICE MARKET BY APPLICATION 2014-2023 ($ MILLION)
  • 10. GLOBAL EXTERNAL BEAM RADIATION THERAPY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 11. GLOBAL INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 12. GLOBAL RADIOTHERAPY DEVICE MARKET BY END-USER 2014-2023 ($ MILLION)
  • 13. GLOBAL HOSPITALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 14. GLOBAL CANCER RESEARCH INSTITUTES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 15. GLOBAL AMBULATORY & RADIOTHERAPY CENTERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 16. NORTH AMERICA RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
  • 17. EUROPE DIGITAL RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
  • 18. ASIA PACIFIC DIGITAL RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
  • 19. REST OF THE WORLD RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL EXTERNAL BEAM RADIOTHERAPY MARKET 2014-2023 ($ MILLION)
  • 2. GLOBAL INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET 2014-2023 ($ MILLION)
  • 3. GLOBAL SYSTEMIC RADIOTHERAPY MARKET 2014-2023 ($ MILLION)
  • 4. GLOBAL EXTERNAL BEAM RADIOTHERAPY MARKET 2014-2023 ($ MILLION)
  • 5. GLOBAL INTERNAL BEAM RADIOTHERAPY MARKET 2014-2023 ($ MILLION)
  • 6. GLOBAL SYSTEMIC RADIOTHERAPY MARKET 2014-2023 ($ MILLION)
  • 7. GLOBAL EXTERNAL BEAM RADIATION THERAPY MARKET 2014-2023 ($ MILLION)
  • 8. GLOBAL INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET 2014-2023 ($ MILLION)
  • 9. GLOBAL HOSPITALS MARKET 2014-2023 ($ MILLION)
  • 10. GLOBAL CANCER RESEARCH INSTITUTES MARKET 2014-2023 ($ MILLION)
  • 11. GLOBAL AMBULATORY & RADIOTHERAPY CENTERS MARKET 2014-2023 ($ MILLION)
  • 12. UNITED STATES (U.S.) RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
  • 13. CANADA RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
  • 14. UNITED KINGDOM (UK) RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
  • 15. FRANCE RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
  • 16. GERMANY RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
  • 17. RUSSIA RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
  • 18. ROE RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
  • 19. INDIA RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
  • 20. CHINA RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
  • 21. JAPAN RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
  • 22. AUSTRALIA RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
  • 23. ROAPAC RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
  • 24. LATIN AMERICA RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)
  • 25. MENA RADIOTHERAPY DEVICE MARKET 2014-2023 ($ MILLION)